Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001827506-24-000095
Filing Date
2024-11-07
Accepted
2024-11-07 08:22:52
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trml-20240930.htm   iXBRL 10-Q 1344234
2 EX-31.1 a09302024exhibit311.htm EX-31.1 9501
3 EX-31.2 a09302024exhibit312.htm EX-31.2 9800
4 EX-32 a09302024exhibit321.htm EX-32 7653
  Complete submission text file 0001827506-24-000095.txt   5706100

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20240930.xsd EX-101.SCH 37603
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trml-20240930_cal.xml EX-101.CAL 50101
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trml-20240930_def.xml EX-101.DEF 190787
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20240930_lab.xml EX-101.LAB 449862
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20240930_pre.xml EX-101.PRE 331321
67 EXTRACTED XBRL INSTANCE DOCUMENT trml-20240930_htm.xml XML 639424
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40384 | Film No.: 241433341
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)